In line with the in vitro results, knockdown of p62 or PRMT6 significantly inhibited in vivo tumor growth compared to control shNC cells with RSL3 administration (Figure 7D-G and Figure S13A-B). The gene discussed is PRMT6; the disease is neoplasm.